Akademisyen
MELEK KARAKURT ERYILMAZ
PROFESÖR
NECMETTİN ERBAKAN ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 138
- Proje 0
- Kitap 1
- Bildiri 0
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
12
Q2
35
Q3
47
Q4
18
WoS (JCR)
Q1
8
Q2
14
Q3
34
Q4
49
TR Index
27
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
0
Ort. yüzdelik
58.3%
Üst %1 payı
0.0%
Üst %10 payı
0.0%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2026 Survival Outcomes and Recurrence Patterns of Early-Stage HER2-Positive Breast Cancer Patients on Adjuvant T-DM1 Treatment: Turkish Oncology Group (TOG) Study YÖKSİS SJR Q2 JCR Q3
- 2025 The efficacy of targeted therapies in metastatic squamous cell carcinoma of the lung: a Turkish Oncology Group multicentre study YÖKSİS SJR Q3 JCR Q3
- 2025 Real‐world comparison of cabozantinib and sunitinib in advanced non‐clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group YÖKSİS SJR Q1 JCR Q2
- 2025 Lorlatinib experience in a patient with ALK + non-small cell lung cancer on hemodialysis: A case report YÖKSİS SJR Q3 JCR Q4
- 2025 Real-world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple-negative breast cancer: A multicenter study by the Turkish Oncology Group YÖKSİS SJR Q1 JCR Q2
- 2025 Impact of Body Composition on Progression-Free Survival in Patients with Metastatic Breast Cancer Treated with Ribociclib YÖKSİS
- 2025 Drug induced lupus associated with Trastuzumab emtansine in a patient with metastatic breast cancer YÖKSİS SJR Q3 JCR Q4 OpenAlex 53.5%
- 2025 Prognostic Impact of Concomitant Beta-Blocker Use on Survival in EGFR-Mutant Metastatic Non-Small Cell Lung Cancer Patients Treated with Erlotinib YÖKSİS SJR Q2 JCR Q1
- 2025 Induction or Adjuvant Chemotherapy in Patients with Locally Advanced Nasopharyngeal Cancer Receiving Chemoradiotherapy? A Turkish Oncology Group Study YÖKSİS SJR Q2 JCR Q1
- 2025 Prognostic Role of Inflammatory and Nutritional Indices in NSCLC Patients Treated with Immune Checkpoint Inhibitors: Retrospective, Multicenter, Turkish Oncology Group Study of Overall and Elderly Populations YÖKSİS SJR Q2 JCR Q1
- 2025 Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Study YÖKSİS SJR Q2 JCR Q2
- 2025 Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival YÖKSİS SJR Q2 JCR Q2
- 2025 The efficacy of targeted therapies in metastatic squamous cell carcinoma of the lung: a Turkish Oncology Group multicentre study YÖKSİS SJR Q3 JCR Q3
- 2025 Lorlatinib experience in a patient with ALK + non-small cell lung cancer on hemodialysis: A case report YÖKSİS SJR Q3 JCR Q4
- 2025 Drug induced lupus associated with Trastuzumab emtansine in a patient with metastatic breast cancer YÖKSİS SJR Q3 JCR Q4
- 2025 Induction or Adjuvant Chemotherapy in Patients with Locally Advanced Nasopharyngeal Cancer Receiving Chemoradiotherapy? A Turkish Oncology Group Study YÖKSİS SJR Q2 JCR Q1
- 2025 Can erythrodermic psoriasis be considered a paraneoplastic syndrome in patients with metastatic occult gastric cancer? YÖKSİS SJR Q4 JCR Q4
- 2025 The rare co-occurrence of cholangiocarcinoma and chronic eosinophilic leukemia YÖKSİS SJR Q4 JCR Q4
- 2025 Leukocytoclastic vasculitis with purpura induced by panitumumab YÖKSİS SJR Q4 JCR Q4
- 2025 Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study YÖKSİS SJR Q3 JCR Q4